{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T06:35:30Z","timestamp":1773470130782,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2314-B-002 -174 -MY3"],"award-info":[{"award-number":["109-2314-B-002 -174 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2314-B-002 -058 -"],"award-info":[{"award-number":["111-2314-B-002 -058 -"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["112-HCH024"],"award-info":[{"award-number":["112-HCH024"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jfma.2023.11.005","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T06:12:23Z","timestamp":1702534343000},"page":"S135-S140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S2","title":["The predictors of long-term outcomes after targeted therapy for primary Aldosteronism"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7864-8793","authenticated-orcid":false,"given":"Ying-Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun-Chen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Ting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5773-676X","authenticated-orcid":false,"given":"Kang-Yung","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0334-790X","authenticated-orcid":false,"given":"Liang-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieh-Kai","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Tung","family":"Shun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2023.11.005_bib1","first-page":"3","article-title":"Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jfma.2023.11.005_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.11.005_bib3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jfma.2023.11.005_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.11.005_bib5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jfma.2023.11.005_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/HYPERTENSIONAHA.120.15679","article-title":"KCNJ5 somatic mutations in aldosterone-producing adenoma are associated with a worse baseline status and better recovery of left ventricular remodeling and diastolic function","volume":"77","author":"Chang","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.11.005_bib7","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1210\/jc.2019-00531","article-title":"KCNJ5 somatic mutation is a predictor of hypertension remission after adrenalectomy for unilateral primary aldosteronism","volume":"104","author":"Vilela","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.11.005_bib8","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa566","article-title":"Arterial stiffness is associated with clinical outcome and cardiorenal injury in lateralized primary aldosteronism","volume":"105","author":"Chan","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.11.005_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.surg.2019.05.001","article-title":"Aldosterone level after saline infusion test could predict clinical outcome in primary aldosteronism after adrenalectomy","volume":"166","author":"Chan","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.jfma.2023.11.005_bib10","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/HYPERTENSIONAHA.120.15328","article-title":"Presence of subclinical hypercortisolism in clinical aldosterone-producing adenomas predicts lower clinical success","volume":"76","author":"Peng","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.11.005_bib11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jfma.2020.04.016","article-title":"Preoperative non-stimulated adrenal venous sampling index for predicting outcomes of adrenalectomy for unilateral primary aldosteronism","volume":"119","author":"Huang","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2023.11.005_bib12","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/SLA.0000000000003200","article-title":"The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism","volume":"272","author":"Burrello","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.jfma.2023.11.005_bib13","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa634","article-title":"Nomogram-based preoperative score for predicting clinical outcome in unilateral primary aldosteronism","volume":"105","author":"Yang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.11.005_bib14","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00268-021-05967-y","article-title":"Outcomes of adrenalectomy and the aldosteronoma resolution score in the black and hispanic population","volume":"45","author":"Romero-Velez","year":"2021","journal-title":"World J Surg"},{"key":"10.1016\/j.jfma.2023.11.005_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jfma.2023.11.005_bib16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.11.005_bib17","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jfma.2023.11.005_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/HYPERTENSIONAHA.119.13131","article-title":"YAssociation between acute fall in estimated glomerular filtration rate after treatment for primary aldosteronism and long-term decline in renal function","volume":"74","author":"Kobayashi","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.11.005_bib19","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1530\/EJE-22-0375","article-title":"Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis","volume":"187","author":"Chen","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfma.2023.11.005_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.644260","article-title":"Composite cardiovascular outcomes in patients with primary aldosteronism undergoing medical versus surgical treatment: a meta-analysis","volume":"12","author":"Huang","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jfma.2023.11.005_bib21","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1210\/js.2019-00019","article-title":"Adrenalectomy improves the long-term risk of end-stage renal disease and mortality of primary aldosteronism","volume":"3","author":"Chen","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jfma.2023.11.005_bib22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cen.13442","article-title":"Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism","volume":"87","author":"Nanba","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jfma.2023.11.005_bib23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/HYPERTENSIONAHA.115.05873","article-title":"Adrenal histopathology in primary aldosteronism: is it time for a change?","volume":"66","author":"Gioco","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.11.005_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12022-021-09667-0","article-title":"What did we learn from the molecular biology of adrenal cortical neoplasia? From histopathology to translational genomics","volume":"32","author":"Juhlin","year":"2021","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.jfma.2023.11.005_bib25","article-title":"Surgical outcomes of aldosterone-producing adenoma on the basis of the histopathological findings","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jfma.2023.11.005_bib26","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/HYPERTENSIONAHA.121.17348","article-title":"Single-center prospective cohort study on the histopathology, genotype, and postsurgical outcomes of patients with primary aldosteronism","volume":"78","author":"Meyer","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.11.005_bib27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MED.0000000000000248","article-title":"Immunohistochemistry of the adrenal in primary aldosteronism","volume":"23","author":"Gomez-Sanchez","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jfma.2023.11.005_bib28","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.11.005_bib29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/eje.0.1470795","article-title":"Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas","volume":"147","author":"Fallo","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfma.2023.11.005_bib30","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1210\/jc.2010-2743","article-title":"Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion","volume":"96","author":"Nakajima","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.11.005_bib31","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1210\/jc.2012-3726","article-title":"Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry","volume":"98","author":"Nanba","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.11.005_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/ERC-21-0287","article-title":"Aldosterone-producing nodules and CYP11B1 signaling correlate in primary aldosteronism","volume":"29","author":"Lin","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jfma.2023.11.005_bib33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/er.2017-00189","article-title":"Genetic causes of functional adrenocortical adenomas","volume":"38","author":"Zennaro","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jfma.2023.11.005_bib34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/HYPERTENSIONAHA.119.14349","article-title":"Somatic CACNA1H mutation as a cause of aldosterone-producing adenoma","volume":"75","author":"Nanba","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.11.005_bib35","doi-asserted-by":"crossref","first-page":"K37","DOI":"10.1530\/EJE-19-0377","article-title":"A somatic mutation in CLCN2 identified in a sporadic aldosterone-producing adenoma","volume":"181","author":"Dutta","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfma.2023.11.005_bib36","doi-asserted-by":"crossref","first-page":"e4066","DOI":"10.1210\/clinem\/dgaa595","article-title":"Prevalence of somatic mutations in aldosterone-producing adenomas in Japanese patients","volume":"105","author":"Nanba","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.11.005_bib37","article-title":"Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population","volume":"5","author":"Wu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfma.2023.11.005_bib38","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.11.005_bib39","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma","volume":"65","author":"Zheng","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.11.005_bib40","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3389\/fendo.2019.00666","article-title":"Prevalence and histopathological characteristics of KCNJ5 mutant aldosterone-producing adenomas in a multi-ethnic Malaysian cohort","volume":"10","author":"Mohideen","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jfma.2023.11.005_bib41","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.11.005_bib42","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2018-01004","article-title":"Targeted molecular characterization of aldosterone-producing adenomas in white Americans","volume":"103","author":"Nanba","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.11.005_bib43","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic characteristics of aldosterone-producing adenomas in blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.11.005_bib44","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/EJE-17-0990","article-title":"Management of endocrine disease: diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited","volume":"179","author":"Williams","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfma.2023.11.005_bib45","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/HJH.0000000000001578","article-title":"KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma","volume":"36","author":"Kitamoto","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2023.11.005_bib46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ans.12470","article-title":"Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism","volume":"85","author":"Ip","year":"2015","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.jfma.2023.11.005_bib47","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00423-013-1093-2","article-title":"Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway","volume":"398","author":"Arnesen","year":"2013","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.jfma.2023.11.005_bib48","article-title":"The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623004710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623004710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:51:27Z","timestamp":1760539887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664623004710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":48,"alternative-id":["S0929664623004710"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2023.11.005","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The predictors of long-term outcomes after targeted therapy for primary Aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2023.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights reserved.","name":"copyright","label":"Copyright"}]}}